Skip to main content

Table 1 Characteristics of studies included in this meta-analysis

From: Association between OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and breast cancer risk: a meta-analysis

First author (Year)

Ethnicity

Sample size (case/control)

Genotyping methods

Matching criteria

Source of control

BC confirmation

Quality scores

SNP studied

HWE(P value)

Ser326Cys

Asp148Glu

Vogel [31]

Caucasian

425/434

Sequencing

Age, menopausal status

PB

NA

7

OGG1 Ser326Cys

0.175

—

Choi [32]

Asian

265/284

PCR-RFLP

NA

HB

Histopatho-

6.5

OGG1 Ser326Cys

0.048

—

Choi [32]

Asian

201/184

PCR-CTPP

Age

HB

Histo-

6

OGG1 Ser326Cys

0.914

—

Huang [16]

Asian

136/232

PCR-RFLP

Age

HB

Patho-

6

OGG1 Ser326Cys APEX1 Asp148Glu

0.525

0.565

Zhang [33]

Caucasian

1571/1244

TaqMan

Age

PB

NA

8

OGG1 Ser326Cys APEX1 Asp148Glu

0.930

0.456

Rossner [34]

Caucasian

1041/1093

FP-TDI

Age

PB

NA

8

OGG1 Ser326Cys

0.857

—

Cai [35]

Asian

1102/1167

TaqMan

Age

PB

NA

8

OGG1 Ser326Cys

0.080

—

Synowiec [36]

Caucasian

41/48

PCR-RFLP

Age

HB

NA

2.5

OGG1 Ser326Cys

0.507

—

Sangrajrang [37]

Asian

506/424

Capillary PCR

Region, menopausal status, drinking, smoking

HB

Histo-

7

OGG1 Ser326Cys APEX1 Asp148Glu

0.627

0.135

Romanowicz-Makowska [38]

Caucasian

100/106

PCR-RFLP

Age

HB

NA

2.5

OGG1 Ser326Cys

0.988

—

Loizidou [39]

Caucasian

1108/1174

TaqMan

Age

PB

Patho-

9.5

OGG1 Ser326Cys

0.499

—

Sterpone [28]

Caucasian

43/34

PCR-SSCP

Age, gender

HB

NA

3

OGG1 Ser326Cys

0.577

—

Ming-Shiean [41]

Asian

401/533

TaqMan

Age

HB

Patho-

6.5

OGG1 Ser326Cys

0.034

—

Roberts [20]

Caucasian

1054/1887

MALDI-TOF

Age, race

PB

Histo-

8

OGG1 Ser326Cys

0.543

—

Smolarz [22]

Caucasian

70/70

PCR-RFLP

Age

HB

Histo-

5

OGG1 Ser326Cys

0.473

—

Kim [17]

Asian

346/351

ASPE

Age, BMI, smoking, drinking

HB

Histo-

6.5

OGG1 Ser326Cys APEX1 Asp148Glu

0.296

0.012

Xie [21]

Asian

630/777

Sequencing

Age, BMI, menopausal status

HB

Patho-

7

OGG1 Ser326Cys

0.161

—

Smith [42]

Caucasian

319/405

TaqMan

Age, race

HB

Histopatho-

7

APEX1 Asp148Glu

—

0.507

Smith [42]

African

53/75

TaqMan

Age, race

HB

Histopatho-

6

APEX1 Asp148Glu

—

0.566

Jelonek [43]

Caucasian

91/412

PCR-RFLP

Age, gender

PB

NA

5

APEX1 Asp148Glu

—

0.092

  1. BC, breast cancer; Histopatho-, Histopathologically confirmed; Histo-, Histologically confirmed; Patho-, Pathologically confirmed; NA, Not available; PB, Population–based; HB, Hospital–based; HWE, Hardy–Weinberg equilibrium in control population; PCR–RFLP, Polymerase chain reaction-restriction fragment length polymorphism; PCR-CTPP, Polymerase chain reaction with confronting two-pair primers; FP-TDI, Template-directed primer extension and detection by fluorescence polarization; PCR-SSCP, Polymerase chain reaction-single strand conformation polymorphism; MALDI-TOF, Matrix-assisted laser desorption/ionization-time of flight mass spectrometry; ASPE, Allele-specific primer extension method.